glp-1 kidney stones Changes in 24-Hour Urine Chemistry in Patients with Nephrolithiasis during Weight Loss with Glucagon-Like Peptide 1–Based Therapies Potential kidney-protective and other effects

A recent study, published in the Journal of Pharmacy and Pharmacology Research, sugges

You dont need to worry about scheduling, measuring or mixing, leaving you more time to focus on you

Objective To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Demand for GLP-1 medications is booming, but healthy, sustained weight loss takes more than just medication

We also present the most up-to-date research involving the pathophysiology of PBH

Early tight control reduces long-term vascular risk